339 related articles for article (PubMed ID: 19426849)
1. OA clinical trials: current targets and trials for OA. Choosing molecular targets: what have we learned and where we are headed?
Hellio Le Graverand-Gastineau MP
Osteoarthritis Cartilage; 2009 Nov; 17(11):1393-401. PubMed ID: 19426849
[TBL] [Abstract][Full Text] [Related]
2. New developments in osteoarthritis and cartilage biology.
Poulet B; Staines KA
Curr Opin Pharmacol; 2016 Jun; 28():8-13. PubMed ID: 26921602
[TBL] [Abstract][Full Text] [Related]
3. Emerging drugs for the treatment of knee osteoarthritis.
Yu SP; Hunter DJ
Expert Opin Emerg Drugs; 2015 Sep; 20(3):361-78. PubMed ID: 25865855
[TBL] [Abstract][Full Text] [Related]
4. Disease-modifying drugs in osteoarthritis: current understanding and future therapeutics.
Oo WM; Yu SP; Daniel MS; Hunter DJ
Expert Opin Emerg Drugs; 2018 Dec; 23(4):331-347. PubMed ID: 30415584
[TBL] [Abstract][Full Text] [Related]
5. Investigational drugs for the treatment of osteoarthritis.
Wang K; Xu J; Hunter DJ; Ding C
Expert Opin Investig Drugs; 2015; 24(12):1539-56. PubMed ID: 26429673
[TBL] [Abstract][Full Text] [Related]
6. Are there promising biologic therapies for osteoarthritis?
Hunter DJ
Curr Rheumatol Rep; 2008 Jan; 10(1):19-25. PubMed ID: 18457607
[TBL] [Abstract][Full Text] [Related]
7. Disease modifying osteoarthritis drugs: facing development challenges and choosing molecular targets.
Le Graverand-Gastineau MP
Curr Drug Targets; 2010 May; 11(5):528-35. PubMed ID: 20199396
[TBL] [Abstract][Full Text] [Related]
8. Emerging pharmaceutical therapies for osteoarthritis.
Latourte A; Kloppenburg M; Richette P
Nat Rev Rheumatol; 2020 Dec; 16(12):673-688. PubMed ID: 33122845
[TBL] [Abstract][Full Text] [Related]
9. Emerging pathways and promising agents with possible disease modifying effect in osteoarthritis treatment.
Jotanovic Z; Mihelic R; Sestan B; Dembic Z
Curr Drug Targets; 2014 Jun; 15(6):635-61. PubMed ID: 24597569
[TBL] [Abstract][Full Text] [Related]
10. The Development of Disease-Modifying Therapies for Osteoarthritis (DMOADs): The Evidence to Date.
Oo WM; Little C; Duong V; Hunter DJ
Drug Des Devel Ther; 2021; 15():2921-2945. PubMed ID: 34262259
[TBL] [Abstract][Full Text] [Related]
11. Pain mechanisms in osteoarthritis: understanding the role of central pain and current approaches to its treatment.
Mease PJ; Hanna S; Frakes EP; Altman RD
J Rheumatol; 2011 Aug; 38(8):1546-51. PubMed ID: 21632678
[TBL] [Abstract][Full Text] [Related]
12. Investigational drugs for the treatment of osteoarthritis, an update on recent developments.
Zhu Z; Li J; Ruan G; Wang G; Huang C; Ding C
Expert Opin Investig Drugs; 2018 Nov; 27(11):881-900. PubMed ID: 30345826
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronans in the treatment of osteoarthritis of the knee: evidence for disease-modifying activity.
Goldberg VM; Buckwalter JA
Osteoarthritis Cartilage; 2005 Mar; 13(3):216-24. PubMed ID: 15727888
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic therapy for osteoarthritis--the era of disease modification.
Hunter DJ
Nat Rev Rheumatol; 2011 Jan; 7(1):13-22. PubMed ID: 21079644
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in intra-articular drug delivery systems for osteoarthritis therapy.
Maudens P; Jordan O; Allémann E
Drug Discov Today; 2018 Oct; 23(10):1761-1775. PubMed ID: 29792929
[TBL] [Abstract][Full Text] [Related]
16. An update on the pathophysiology of osteoarthritis.
Mobasheri A; Batt M
Ann Phys Rehabil Med; 2016 Dec; 59(5-6):333-339. PubMed ID: 27546496
[TBL] [Abstract][Full Text] [Related]
17. Rationale for the use of structure-modifying drugs and agents in the treatment of osteoarthritis.
Pelletier JP
Osteoarthritis Cartilage; 2004; 12 Suppl A():S63-8. PubMed ID: 14698646
[TBL] [Abstract][Full Text] [Related]
18. Osteoarthritic pain: a review of current, theoretical and emerging therapeutics.
Read SJ; Dray A
Expert Opin Investig Drugs; 2008 May; 17(5):619-40. PubMed ID: 18447590
[TBL] [Abstract][Full Text] [Related]
19. OARSI Clinical Trials Recommendations: Design and conduct of clinical trials for hand osteoarthritis.
Kloppenburg M; Maheu E; Kraus VB; Cicuttini F; Doherty M; Dreiser RL; Henrotin Y; Jiang GL; Mandl L; Martel-Pelletier J; Nelson AE; Neogi T; Pelletier JP; Punzi L; Ramonda R; Simon LS; Wang S;
Osteoarthritis Cartilage; 2015 May; 23(5):772-86. PubMed ID: 25952348
[TBL] [Abstract][Full Text] [Related]
20. Prospects for disease modification in osteoarthritis.
Abramson SB; Attur M; Yazici Y
Nat Clin Pract Rheumatol; 2006 Jun; 2(6):304-12. PubMed ID: 16932709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
